|
(IUPAC) name[4-(4-amino-6,7-dimethoxy- quinazolin-2-yl) piperazin-1-yl]- (2,5-dioxabicyclo[4.4.0] deca-6,8,10-trien-4-yl) methanoneIdentifiersCAS ic doxazosin mesylate 74191-85-8ATC code C02CA04PubChem 3157DrugBank APRD00474Chemical dataFormula C23H25N5O5Mol. mass 451.475 g/molPharmacokinetic dataBioavailability.
HepaticHalf life 22 hoursExcretion ic doxazosin mesylate ?Therapeutic considerationsPregnancy ic doxazosin mesylate ?Legal status ? Prescription ic doxazosin mesylate oralDoxazosin mesylate, a quinazoline compound sold by ic doxazosin mesylate under the brand names Cardura® and Carduran® , is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to be marketed as Cardura® XL.It is an alpha ic doxazosin mesylate used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the ic doxazosin mesylate FDA approved a sustained release ic doxazosin mesylate of doxazosin, to be marketed as Cardura® XL.It is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to be ic doxazosin mesylate as Cardura® XL.It is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form ic doxazosin mesylate doxazosin.
methanoneIdentifiersCAS number 74191-85-8ATC code C02CA04PubChem 3157DrugBank.
| 
Comments
I have seen all...
__________________
To whom is the link to the ic doxazosin mesylate necessary?
__________________
__________________
__________________
It is very necessary!
I have found it!
It is very necessary!